Financhill
Back

Aligos Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALGS is experiencing selling pressure, which indicates risk of future bearish movement.

Aligos Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 25.46 Sell
20-day SMA: 27.71 Sell
50-day SMA: 32.07 Sell
200-day SMA: 17.81 Buy
8-day EMA: 25.38 Sell
20-day EMA: 27.68 Sell
50-day EMA: 28.15 Sell
200-day EMA: 21.58 Sell

Aligos Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.21 Sell
Relative Strength Index (14 RSI): 34.79 Sell
Chaikin Money Flow: -518328 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.35 - 34.19) Sell
Bollinger Bands (100): (9.82 - 33.5) Sell

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Aligos Therapeutics Stock

Is Aligos Therapeutics Stock a Buy?

ALGS Technical Analysis vs Fundamental Analysis

Sell
37
Aligos Therapeutics (ALGS) is a Sell

Is Aligos Therapeutics a Buy or a Sell?

Aligos Therapeutics Stock Info

Market Cap:
75.4M
Price in USD:
21.01
Share Volume:
713.1K

Aligos Therapeutics 52-Week Range

52-Week High:
46.80
52-Week Low:
6.76
Sell
37
Aligos Therapeutics (ALGS) is a Sell

Aligos Therapeutics Share Price Forecast

Is Aligos Therapeutics Stock a Buy?

  • Aligos Therapeutics share price is 21.01 while ALGS 8-day exponential moving average is 25.38, which is a Sell signal.
  • The stock price of ALGS is 21.01 while Aligos Therapeutics 20-day EMA is 27.68, which makes it a Sell.
  • Aligos Therapeutics 50-day exponential moving average is 28.15 while ALGS share price is 21.01, making it a Sell technically.
  • ALGS stock price is 21.01 and Aligos Therapeutics 200-day simple moving average is 21.58, creating a Sell signal.

Fundamental Analysis of Aligos Therapeutics

Is Aligos Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Technical Analysis of Aligos Therapeutics

Should I short Aligos Therapeutics stock?

* Aligos Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.